Rankings
▼
Calendar
CRON Q4 2020 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
CRON
Cronos Group Inc.
$983M
Q4 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$17M
Gross Profit
-$15M
-87.4% margin
Operating Income
-$58M
-342.7% margin
Net Income
-$111M
-652.5% margin
EPS (Diluted)
$-0.32
QoQ Revenue Growth
+50.1%
Cash Flow
Operating Cash Flow
-$38M
Free Cash Flow
-$49M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$218M
Stockholders' Equity
$1.7B
Cash & Equivalents
$1.1B
Revenue Segments
Cannabis Flower
$12M
68%
Cannabis Extracts
$5M
32%
Product and Service, Other
$43,000
0%
Geographic Segments
CANADA
$12M
69%
UNITED STATES
$4M
21%
Other Countries
$2M
10%
← FY 2020
All Quarters
Q1 2021 →